46 Views | 13 Downloads
Jessica L. Maples-Keller, Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University, Atlanta, GA 30329. jessmaples@gmail.com
The present study was supported by NARSAD 19798 (BOR), R01 MH094757 (KJR), R01 MH096764 (KJR), R01 MH071537 (KJR), Howard Hughes Medical Institute, and National Center for Advancing Translational Sciences of the National Institutes of Health under Award number UL1TR002378 and UL1 TR000424. Rothbaum received funding from Wounded Warrior Project, Department of Defense Clinical Trial (Grant No. W81XWH-10-1-1045) and McCormick Foundation.
Rothbaum received royalties from Oxford University Press, Guilford, APPI, and Emory University and received advisory board payments from Genentech, Jazz Pharmaceuticals, Nobilis Therapeutics, Neuronetics, and Aptinyx. Other authors declare that there are no conflict of interests.
Howard Hughes Medical Institute; National Alliance for Research on Schizophrenia and Depression, Grant/Award Number: 19798; National Institute of Mental Health, Grant/Award Numbers: 071537, 094757, 096764; National Center for Advancing Translational Sciences of the National Institutes of Health, Grant/Award Numbers: TR000424, UL1TR002378